 |
 |

Absence of TH2 Cytokine Messenger RNA Expression in CD30-Negative Primary Cutaneous Large T-Cell Lymphomas
Maarten H. Vermeer, MD;
Cornelis P. Tensen, PhD;
Petra M. van der Stoop;
Hans W. van Oostveen, PhD;
Marianne Lund;
Rik J. Scheper, PhD;
Rein Willemze, MD, PhD
Arch Dermatol. 2001;137:901-905.
Background Previous studies demonstrating that the neoplastic cells in Sézary syndrome and tumor stage mycosis fungoides express interleukin 4 (IL-4), IL-5, and IL-10 have resulted in the concept that cutaneous T-cell lymphomas are derived from CD4+ T cells with a TH2 type cytokine profile.
Objective To determine the cytokine profile in CD30- primary cutaneous large T-cell lymphomas, which represent a subgroup of cutaneous T-cell lymphoma with an aggressive clinical behavior (5-year survival rate of 15%).
Design and Methods Seven biopsy specimens were taken from 4 patients with CD30- primary cutaneous large T-cell lymphomas and studied for the expression of TH1 (IL-2 and interferon ) and TH2 (IL-4, IL-5, IL-10) cytokines using a reverse transcriptionpolymerase chain reaction technique. Skin biopsy specimens from patients with Sézary syndrome, mycosis fungoides, atopic dermatitis, or psoriasis were included as controls.
Results In the 7 CD30- primary cutaneous large T-cell lymphomas showing an almost pure population of large tumor cells (>90%), no expression of IL-4 was found, and IL-5 was only found in 1 of 7 cases. In control biopsy specimens, expression of IL-4 and/or IL-5 was demonstrated in atopic dermatitis (3/3), tumor stage mycosis fungoides (2/2), and Sézary syndrome (3/3), but not in plaque stage mycosis fungoides.
Conclusion Our results demonstrate that CD30- primary cutaneous large T-cell lymphomas do not produce TH2 cytokines, illustrating that not all cutaneous T-cell lymphomas have a TH2 cytokine profile.
From the Departments of Dermatology (Drs Vermeer, Tensen, van Oostveen, and Willemze and Ms van der Stoop) and Pathology (Drs Tensen, van Oostveen, and Scheper), Free University Hospital, Amsterdam, the Netherlands; and Department of Dermatology, Marselisborg Hospital, Aarhus, Denmark (Ms Lund).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma
Kleinhans et al.
Blood 2003;101:1487-1493.
ABSTRACT
| FULL TEXT
|